308 related articles for article (PubMed ID: 24578620)
21. The effect of curcumin on cognition in Alzheimer's disease and healthy aging: A systematic review of pre-clinical and clinical studies.
Voulgaropoulou SD; van Amelsvoort TAMJ; Prickaerts J; Vingerhoets C
Brain Res; 2019 Dec; 1725():146476. PubMed ID: 31560864
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological considerations for treating neuroinflammation with curcumin in Alzheimer's disease.
Zhou X; Venigalla M; Raju R; Münch G
J Neural Transm (Vienna); 2022 Jun; 129(5-6):755-771. PubMed ID: 35294663
[TBL] [Abstract][Full Text] [Related]
23. Letter to the editor.
Monfared-Asl R
Int J Biol Macromol; 2019 Mar; 125():1212-1213. PubMed ID: 30236753
[TBL] [Abstract][Full Text] [Related]
24. Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease.
Baum L; Lam CW; Cheung SK; Kwok T; Lui V; Tsoh J; Lam L; Leung V; Hui E; Ng C; Woo J; Chiu HF; Goggins WB; Zee BC; Cheng KF; Fong CY; Wong A; Mok H; Chow MS; Ho PC; Ip SP; Ho CS; Yu XW; Lai CY; Chan MH; Szeto S; Chan IH; Mok V
J Clin Psychopharmacol; 2008 Feb; 28(1):110-3. PubMed ID: 18204357
[No Abstract] [Full Text] [Related]
25. Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease.
Reddy PH; Manczak M; Yin X; Grady MC; Mitchell A; Tonk S; Kuruva CS; Bhatti JS; Kandimalla R; Vijayan M; Kumar S; Wang R; Pradeepkiran JA; Ogunmokun G; Thamarai K; Quesada K; Boles A; Reddy AP
J Alzheimers Dis; 2018; 61(3):843-866. PubMed ID: 29332042
[TBL] [Abstract][Full Text] [Related]
26. [Neuroprotective effects of curcumin].
Li Y; Wang P
Zhongguo Zhong Yao Za Zhi; 2009 Dec; 34(24):3173-5. PubMed ID: 20352992
[TBL] [Abstract][Full Text] [Related]
27. The potential therapeutic effects of curcumin on pregnancy complications: Novel insights into reproductive medicine.
Ghaneifar Z; Yousefi Z; Tajik F; Nikfar B; Ghalibafan F; Abdollahi E; Momtazi-Borojeni AA
IUBMB Life; 2020 Dec; 72(12):2572-2583. PubMed ID: 33107698
[TBL] [Abstract][Full Text] [Related]
28. Curcumin and Its Derivatives as Theranostic Agents in Alzheimer's Disease: The Implication of Nanotechnology.
Shabbir U; Rubab M; Tyagi A; Oh DH
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33375513
[TBL] [Abstract][Full Text] [Related]
29. Bidirectional interactions between curcumin and gut microbiota in transgenic mice with Alzheimer's disease.
Sun ZZ; Li XY; Wang S; Shen L; Ji HF
Appl Microbiol Biotechnol; 2020 Apr; 104(8):3507-3515. PubMed ID: 32095862
[TBL] [Abstract][Full Text] [Related]
30. The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update.
Ghosh S; Banerjee S; Sil PC
Food Chem Toxicol; 2015 Sep; 83():111-24. PubMed ID: 26066364
[TBL] [Abstract][Full Text] [Related]
31. Curcuminoids and resveratrol as anti-Alzheimer agents.
Villaflores OB; Chen YJ; Chen CP; Yeh JM; Wu TY
Taiwan J Obstet Gynecol; 2012 Dec; 51(4):515-25. PubMed ID: 23276553
[TBL] [Abstract][Full Text] [Related]
32. Curcumin and inflammatory bowel disease: biological mechanisms and clinical implication.
Ali T; Shakir F; Morton J
Digestion; 2012; 85(4):249-55. PubMed ID: 22950087
[TBL] [Abstract][Full Text] [Related]
33. A Comprehensive Review on the Benefits and Problems of Curcumin with Respect to Human Health.
Liu S; Liu J; He L; Liu L; Cheng B; Zhou F; Cao D; He Y
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889273
[TBL] [Abstract][Full Text] [Related]
34. Non-steroidal anti-inflammatory drugs as a treatment for Alzheimer's disease: a systematic review and meta-analysis of treatment effect.
Miguel-Álvarez M; Santos-Lozano A; Sanchis-Gomar F; Fiuza-Luces C; Pareja-Galeano H; Garatachea N; Lucia A
Drugs Aging; 2015 Feb; 32(2):139-47. PubMed ID: 25644018
[TBL] [Abstract][Full Text] [Related]
35. Clinical development of curcumin in neurodegenerative disease.
Hu S; Maiti P; Ma Q; Zuo X; Jones MR; Cole GM; Frautschy SA
Expert Rev Neurother; 2015 Jun; 15(6):629-37. PubMed ID: 26035622
[TBL] [Abstract][Full Text] [Related]
36. Supplementation with Curcuma longa Reverses Neurotoxic and Behavioral Damage in Models of Alzheimer's Disease: A Systematic Review.
da Costa IM; Freire MAM; de Paiva Cavalcanti JRL; de Araújo DP; Norrara B; Moreira Rosa IMM; de Azevedo EP; do Rego ACM; Filho IA; Guzen FP
Curr Neuropharmacol; 2019; 17(5):406-421. PubMed ID: 29338678
[TBL] [Abstract][Full Text] [Related]
37. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease.
Jaturapatporn D; Isaac MG; McCleery J; Tabet N
Cochrane Database Syst Rev; 2012 Feb; (2):CD006378. PubMed ID: 22336816
[TBL] [Abstract][Full Text] [Related]
38. Curcumin in Health and Diseases: Alzheimer's Disease and Curcumin Analogues, Derivatives, and Hybrids.
Chainoglou E; Hadjipavlou-Litina D
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183162
[TBL] [Abstract][Full Text] [Related]
39. The targets of curcumin.
Zhou H; Beevers CS; Huang S
Curr Drug Targets; 2011 Mar; 12(3):332-47. PubMed ID: 20955148
[TBL] [Abstract][Full Text] [Related]
40. Curcumin and Resveratrol in the Management of Cognitive Disorders: What is the Clinical Evidence?
Mazzanti G; Di Giacomo S
Molecules; 2016 Sep; 21(9):. PubMed ID: 27649135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
